Fagron Compounding Services recalls norepinephrine Bitartrate
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Lack of Assurance of Sterility; blue Break-Off-Part could detach from the administration port
- Products
-
- norepinephrine Bitartrate
- Company
- Fagron Compounding Services
- Where it was sold
-
Nationwide in the U.S.A.
Nationwide
- Units affected
- 5140 bags
- About this recall
- norepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02